Ethnic disparity in intracranial hemorrhage among anticoagulated patients with atrial fibrillation: an answer in search of a question?

troke due to intracranial hemorrhage (ICH) carries a igher morbidity and mortality than ischemic stroke, and it as been estimated that among persons 45 to 64 years of ge, 8% to 12% of ischemic strokes and 37% to 38% of emorrhagic strokes result in death within 30 days (1). The isk of ICH is increased among patients receiving heparin or arfarin, and the mortality of anticoagulant-associated ICH s approximately double that of spontaneous ICH (1–4). trial fibrillation (AF) is an independent risk factor for schemic stroke. It increases stroke risk about 5-fold, and his risk is significantly reduced by warfarin.